Malaria incidence in Myanmar 2005-2014: Steady but fragile progress towards elimination

Malaria Journal

Volumn 15, Issue 1, 2016, Pages

  Mu, Thet Thet ^a   Sein, Aye Aye ^a   Kyi, Tint Tint ^a   Min, Myo ^b   Aung, Ne Myo ^c   Anstey, Nicholas M ^d   Kyaw, Myat Phone ^e   Soe, Chit ^f   Kyi, Mar Mar ^c   Hanson, Josh ^c,d,g  

^a DEPARTMENT OF HEALTH   (Myanmar)

^b Myanmar Medical Association   (Myanmar)

^c University of Medicine 2   (Myanmar)

^d MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^e Department of Medical Research ^*  (Myanmar)

^f University of Medicine (1)   (Myanmar)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Artemisinin resistance; Epidemiology; Greater Mekong Region; Malaria; Myanmar; Public health

Indexed keywords

ARTEMISININ; ANTIMALARIAL AGENT; ARTEMISIN; ARTEMISININ DERIVATIVE; LACTONE;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; COMBINATION DRUG THERAPY; DEFORESTATION; DEMOGRAPHY; HEALTH AUXILIARY; HEALTH CARE ACCESS; HEALTH PROGRAM; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; INSECTICIDE TREATED NET; INTERNATIONAL COOPERATION; INVESTMENT; MAJOR CLINICAL STUDY; MALARIA; MORBIDITY; MORTALITY RATE; MYANMAR; PARASITE CLEARANCE; PARASITE CONTROL; SOCIOECONOMICS; DRUG EFFECTS; DRUG RESISTANCE; MORTALITY; PLASMODIUM; SURVIVAL ANALYSIS;

ANTIMALARIALS; ARTEMISININS; DRUG RESISTANCE; HUMANS; INCIDENCE; LACTONES; MALARIA; MYANMAR; PLASMODIUM; SURVIVAL ANALYSIS;

EID: 84992202542     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-016-1567-0     Document Type: Article

References (48)

1. WHO. World Malaria Report 2015. Geneva: World Health Organization; 2015.
2. WHO. Strategy for malaria elimination in the greater Mekong subregion (2015-2030). World Health Organization Regional Office for the Western Pacific; 2015.
3. Worrall E, Basu S, Hanson K. Is malaria a disease of poverty? A review of the literature. Trop Med Int Health. 2005;10:1047-59.
4. Smith C, Whittaker M. Beyond mobile populations: a critical review of the literature on malaria and population mobility and suggestions for future directions. Malar J. 2014;13:307.
5. Menard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med. 2016;374:2453-64.
6. Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis. 2015;15:415-21.
7. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455-67.
8. Hay SI, Okiro EA, Gething PW, Patil AP, Tatem AJ, Guerra CA, et al. Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. PLoS Med. 2010;7:e1000290.
9. Parker DM, Carrara VI, Pukrittayakamee S, McGready R, Nosten FH. Malaria ecology along the Thailand-Myanmar border. Malar J. 2015;14:388.
10. Nyunt MH, Aye KM, Kyaw KT, Han SS, Aye TT, Wai KT, et al. Challenges encountered by local health volunteers in early diagnosis and prompt treatment of malaria in Myanmar artemisinin resistance containment zones. Malar J. 2016;15:308.
11. Lwin MM, Sudhinaraset M, San AK, Aung T. Improving malaria knowledge and practices in rural Myanmar through a village health worker intervention: a cross-sectional study. Malar J. 2014;13:5.
12. Nyunt MH, Aye KM, Kyaw MP, Kyaw TT, Hlaing T, Oo K, et al. Challenges in universal coverage and utilization of insecticide-treated bed nets in migrant plantation workers in Myanmar. Malar J. 2014;13:211.
13. Aung T, White C, Montagu D, McFarland W, Hlaing T, Khin HS, et al. Improving uptake and use of malaria rapid diagnostic tests in the context of artemisinin drug resistance containment in eastern Myanmar: an evaluation of incentive schemes among informal private healthcare providers. Malar J. 2015;14:105.
14. Strategic framework for artemisinin resistance containment in Myanmar (MARC) 2011-2015. World Health Organization, South-East Asia Regional Office; 2011.
15. National Strategic Plan. Malaria prevention and control 2010-2016. Republic of the Union of Myanmar: Department of Health; 2014.
16. Khin HS, Aung T, Thi A, White C. Oral artemisinin monotherapy removal from the private sector in Eastern Myanmar between 2012 and 2014. Malar J. 2016;15:286.
17. Drake TL, Kyaw SS, Kyaw MP, Smithuis FM, Day NP, White LJ, et al. Cost effectiveness and resource allocation of Plasmodium falciparum malaria control in Myanmar: a modelling analysis of bed nets and community health workers. Malar J. 2015;14:376.
18. Kyaw SS, Drake T, Thi A, Kyaw MP, Hlaing T, Smithuis FM, et al. Malaria community health workers in Myanmar: a cost analysis. Malar J. 2016;15:41.
19. Spoorenberg T. Demographic changes in Myanmar since 1983: an examination of official data. Popul Dev Rev. 2013;39:309-24.
20. Carrara VI, Lwin KM, Phyo AP, Ashley E, Wiladphaingern J, Sriprawat K, et al. Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study. PLoS Med. 2013;10:e1001398.
21. Kaung M, Kyi TT, Aung NM, Kyaw MP, Min M, Htet ZW, et al. The prognostic utility of bedside assessment of adults hospitalized with malaria in Myanmar: a retrospective analysis. Malar J. 2015;14:63.
22. Li S, Yin S, Wang J, Li X, Feng J. Shifting from control to elimination: analysis of malaria epidemiological characteristics in Tengchong County around China-Myanmar border, 2005-2014. Malar J. 2016;15:45.
23. Phyo AP, Ashley EA, Anderson TJ, Bozdech Z, Carrara VI, Sriprawat K, et al. Declining efficacy of artemisinin combination therapy against P. falciparum malaria on the Thai-Myanmar border (2003-2013): the role of parasite genetic factors. Clin Infect Dis. 2016;63:784-91.
24. Khin HS, Chen I, White C, Sudhinaraset M, McFarland W, Littrell M, et al. Availability and quality of anti-malarials among private sector outlets in Myanmar in 2012: results from a large, community-based, cross-sectional survey before a large-scale intervention. Malar J. 2015;14:269.
25. Landier J, Parker DM, Thu AM, Carrara VI, Lwin KM, Bonnington CA, et al. The role of early detection and treatment in malaria elimination. Malar J. 2016;15:363.
26. Aung T, Lwin MM, Sudhinaraset M, Wei C. Rural and urban disparities in health-seeking for fever in Myanmar: findings from a probability-based household survey. Malar J. 2016;15:386.
27. Smith Paintain L, Willey B, Kedenge S, Sharkey A, Kim J, Buj V, et al. Community health workers and stand-alone or integrated case management of malaria: a systematic literature review. Am J Trop Med Hyg. 2014;91:461-70.
28. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev. 2004;2:CD000363.
29. Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526:207-11.
30. Lin K, Aung S, Lwin S, Min H, Aye NN, Webber R. Promotion of insecticide-treated mosquito nets in Myanmar. South east Asian J Trop Med Public Health. 2000;31:444-7.
31. Nosten F, White NJ. Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg. 2007;77(6 Suppl):181-92.
32. Kyaw MP, Nyunt MH, Chit K, Aye MM, Aye KH, Lindegardh N, et al. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. PLoS ONE. 2013;8:e57689.
33. Fairhurst RM. High Antimalarial efficacy of dihydroartemisinin-piperaquine on the China-Myanmar border: the calm before the storm. Am J Trop Med Hyg. 2015;93:436-7.
34. Tumwebaze P, Conrad MD, Walakira A, LeClair N, Byaruhanga O, Nakazibwe C, et al. Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children. Antimicrob Agents Chemother. 2015;59:3018-30.
35. Wang Y, Yang Z, Yuan L, Zhou G, Parker D, Lee MC, et al. Clinical efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria at the China-Myanmar border. Am J Trop Med Hyg. 2015;93:577-83.
36. Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C, et al. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis. 2016;16:357-65.
37. Thriemer K, Hong NV, Rosanas-Urgell A, Phuc BQ, Ha do M, Pockele E, et al. Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central Vietnam. Antimicrob Agents Chemother. 2014;58:7049-55.
38. Lun ZR, Ferreira PE, Fu LC. Artemisinin resistance in Plasmodium falciparum. Lancet Infect Dis. 2014;14:450-1.
39. White NJ. Can new treatment developments combat resistance in malaria? Expert Opin Pharmacother. 2016;17:1303-7.
40. Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015;93:125-34.
41. Homan T, Hiscox A, Mweresa CK, Masiga D, Mukabana WR, Oria P, et al. The effect of mass mosquito trapping on malaria transmission and disease burden (SolarMal): a stepped-wedge cluster-randomised trial. Lancet. 2016;388:1193-201.
42. Chin State profile [ http://www.unicef.org/myanmar/Chin-State-Profile-30-07-15.pdf ]. Accessed on oct 2016.
43. East Asia's Changing Urban Landscape. Measuring a decade of spatial growth. Washington, DC: The World Bank; 2015.
44. Wang C, Myint SW. Environmental concerns of deforestation in Myanmar 2001-2010. Remote Sens. 2016;8:728.
45. Ool TT, Storch V, Becker N. Review of the anopheline mosquitoes of Myanmar. J Vector Ecol. 2004;29:21-40.
46. The 2014 Myanmar population and housing census. Department of Population. Ministry of Immigration and Population; 2015.
47. Oliveira-Ferreira J, Lacerda MV, Brasil P, Ladislau JL, Tauil PL, Daniel-Ribeiro CT. Malaria in Brazil: an overview. Malar J. 2010;9:115.
48. Najera JA, Gonzalez-Silva M, Alonso PL. Some lessons for the future from the Global Malaria Eradication Programme (1955-1969). PLoS Med. 2011;8:e1000412.